Cost-utility and budget impact analyses of anaplastic lymphoma kinase inhibitors in Thailand. [PDF]
Luksameesate P +5 more
europepmc +1 more source
Anaplastic lymphoma kinase-negative inflammatory myofibroblastic tumor of the appendix and ileocecal region: a rare clinical entity. [PDF]
Sánchez-Villegas MG +5 more
europepmc +1 more source
Anaplastic Lymphoma Kinase (ALK)-Positive Anaplastic Large Cell Lymphoma Presenting as an Axillary Breast Abscess in a Young Woman: A Case Report. [PDF]
Amamnkwah D, Ibrahim F.
europepmc +1 more source
Anaplastic lymphoma kinase-positive primary CNS anaplastic large cell lymphoma in a pediatric patient: illustrative case. [PDF]
Dolen Burak D +7 more
europepmc +1 more source
Neoadjuvant Alectinib in a Patient With Anaplastic Lymphoma Kinase (ALK)-Mutant Stage III Lung Adenocarcinoma: A Case Report. [PDF]
Dastagir ML, Bajaman J, Reynolds JA.
europepmc +1 more source
Response to anaplastic lymphoma kinase inhibitor in gastric cancer harboring <i>DCTN1-ALK</i> fusion: a case report and review. [PDF]
Wang H, You L, Pan H, Qiu X, Sheng J.
europepmc +1 more source
Vaginal Anaplastic Lymphoma Kinase (ALK)-Positive Mesenchymal Tumor in a Young Patient: Expanding the Spectrum of Rare Genitourinary Neoplasms. [PDF]
Hassan D +2 more
europepmc +1 more source
High-Speed Atomic Force Microscopy Reveals Disordered Region-Mediated Structural Plasticity of Anaplastic Lymphoma Kinase Fusion Proteins Induced by Inhibitors. [PDF]
Han X +13 more
europepmc +1 more source
Primary Gingival Anaplastic Lymphoma Kinase (ALK)-Positive Anaplastic Large Cell Lymphoma in a Young Boy. [PDF]
Lutz CM, Bruneau J, Molina TJ, Ejeil AL.
europepmc +1 more source

